Sign Up to Receive Your Personalised Learning Resources
![](https://touchoncology.com/wp-content/uploads/sites/2/2020/04/Covid_1.jpg)
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
A New Frontier in the Treatment of Epidermal Growth Factor Receptor-mutated Non–Small-Cell Lung Cancer: Amivantamab-vmjw and Chemotherapy
View
FUTURE LEADERS: Shaping the future of cancer treatment with Dr Yuri Yoshinami
View
FUTURE LEADERS: Shaping the future of melanoma and sarcoma with Dr Rodrigo Munhoz
View
Advances in Targeting KRAS G12C in Gastrointestinal Malignancies: Focus on KRAS G12C Inhibitors
View
Durvalumab with neoadjuvant chemotherapy and radical cystectomy in muscle-invasive bladder cancer
View
Nivolumab plus Relatlimab alongside chemotherapy demonstrated improved clinical benefit in the RELATIVITY-104 trial
View
World Cancer Day 2025: “United by Unique”
View
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
View
ESMO Congress 2024 – 13 – 17 September, Barcelona Spain
View
Dostarlimab for the Treatment of Endometrial Cancer: A Review
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a
.This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.